Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
Caroline Schoenherr(Medizinische Hochschule Hannover), Melanie Ricke‐Hoch(Medizinische Hochschule Hannover)
Cited by 0